Development new radioimmunoassay erythropoietin recombinant erythropoietin development hour radioimmunoassay erythropoietin EPO EPO recombinant DNA immunogen ligand present paper Mixed rabbits micrograms/kg EPO cell line Elanex Pharmaceuticals Bothel Washington USA McDonnell Douglas Louis Missouri USA MD antibodies EPO high titer final dilution tube high affinity liter/M good specificity EPO source AmGen Biologicals Thousand Oaks California USA AG chloramine-T method ligand radioimmunoassay Standard dose-response curves EPO commercial sources different sensitivity mU/tube dose-response curves systems parallelism serum patient aplastic anemia Within-assay between-assay precision multiple replicates serum pool Recovery exogenous EPO serum pool systems range normal human serum EPO sera hematologically-normal adult subjects mU/ml MD EPO mU/ml AG EPO Sera several patients hematologic abnormalities patients anemia end-stage renal disease mean SEM mU/ml conclusion new rapid sensitive radioimmunoassay system EPO levels sera normal human subjects patients several types anemia useful therapeutic drug monitoring patients EPO various commercial sources 